Efficacy evaluation of intravenous immunoglobulin in non-severe patients with COVID-19: A retrospective cohort study based on propensity score matching
Objectives: At the present time, there is an absence of any proven effective antiviral therapy for patients with coronavirus disease 2019 (COVID-19). The aim of this study was to assess the efficacy of intravenous immunoglobulin (IVIG) in non-severe patients with COVID-19. Methods: A retrospective s...
Main Authors: | Chenlu Huang, Ling Fei, Weixia Li, Wei Xu, Xudong Xie, Qiang Li, Liang Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-04-01
|
Series: | International Journal of Infectious Diseases |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1201971221000151 |
Similar Items
-
Efficacy Evaluation of Thymosin Alpha 1 in Non-severe Patients With COVID-19: A Retrospective Cohort Study Based on Propensity Score Matching
by: ChenLu Huang, et al.
Published: (2021-04-01) -
Potential therapeutic approach of intravenous immunoglobulin against COVID-19
by: Zahra Kolahchi, et al.
Published: (2021-10-01) -
Treatment of a case of COVID-19 by intravenous immunoglobulin
by: Mustafa Çolak, et al.
Published: (2021-03-01) -
The use of intravenous immunoglobulin gamma for the treatment of severe coronavirus disease 2019: a randomized placebo-controlled double-blind clinical trial
by: Naser Gharebaghi, et al.
Published: (2020-10-01) -
Efficacy Evaluation of Early, Low-Dose, Short-Term Corticosteroids in Adults Hospitalized with Non-Severe COVID-19 Pneumonia: A Retrospective Cohort Study
by: Qiang Li, et al.
Published: (2020-09-01)